论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Li X, Li F, Wang FF, Li JF, Lin CZ, Du JX
Received 20 November 2017
Accepted for publication 5 March 2018
Published 22 May 2018 Volume 2018:11 Pages 2981—2989
DOI https://doi.org/10.2147/OTT.S157613
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Dr Ingrid Espinoza
Purpose: The aim was to
investigate resveratrol effects on A549 cells proliferation.
Methods: A total of 104 lung adenocarcinoma tissues and
nontumor tissues were collected. BEAS-2B cells were cultured in RPMI 1640
medium (group A). A549 cells were treated with RPMI 1640 medium containing
different resveratrol concentrations. A549 cells were transfected and grouped
as follows: blank group, siRNA-negative control group, siRNA-COX-2 group and
resveratrol + siRNA-COX-2 group. qRT-PCR and Western blot were conducted to
detect COX-2 expression. MTT assay,
soft agar clone assay and flow cytometry were performed to assess proliferation
and cell cycle.
Results: The relative expression of COX-2 mRNA was significantly
increased in lung adenocarcinoma tissues (P <0.01) and it
was closely related with clinical stages. Resveratrol at 60 µmol/L
significantly inhibited A549 cells proliferation, S phase cells proportion
and COX-2 expression (P <0.01). COX-2 expression in
siRNA-COX-2 group was significantly lower than that in blank group and
siRNA-negative control group (P <0.01). OD570 values, colony formation rate and S phase cells
proportion of resveratrol + siRNA-COX-2 group were much lower than those of
other groups (P <0.01).
Conclusion: Resveratrol inhibits A549 cells proliferation by
inhibiting COX-2 expression.
Keywords: resveratrol, COX-2 expression, A549 cell,
proliferation